News
MEDICA, November 14-17, Düsseldorf, Germany
October 26 2012
ASN Kidney Week 2012, Oct. 30 – Nov. 4, San Diego, CA, USA
October 12 2012
The NGAL Test™ now available for users of Siemens instruments
September 05 2012
AACC-CLINICAL LAB EXPO 2012 July 15-19, Los Angeles,USA
July 12 2012
Nordic Society for Clinical Chemistry, June 12-15, Reykjavik, Iceland
May 22 2012
ERA-EDTA, May 24-27, Paris, France
May 08 2012
BioPorto Diagnostics Product overview 2012
March 02 2012
ISICEM 2012, March 20-23, Brussels, Belgium
February 23 2012
CRITICARE, February 15-19, Pune, India
January 24 2012
Conference on Continuous Renal Replacement Therapies (CRRT), February 12-15, San Diego, USA
January 24 2012
MEDICA, November 16-19, Düsseldorf, Germany
October 26 2011 by BioPorto Diagnostics
The world’s largest medical trade fair, MEDICA, introduces a wide variety of innovations and know-how in the world of healthcare.
BioPorto Diagnostics will be represented at MEDICA, promoting The NGAL Test™, designed for measuring the emerging biomarker NGAL.
What is NGAL?
NGAL is a biomarker for diagnosing acute kidney injury (AKI). The biomarker has been recognised by the market as a new way to identify patients at risk of developing potentially severe acute kidney injury (AKI).
Meet BioPorto Diagnostics representatives at stand K88, Hall 3, or contact us prior to the congress for an appointment at info@bioporto.com
For further information on MEDICA, please click here
